Back to Search
SHARI SCUDDER, B.S., PHARMD
B.S., PHARMD
Pharmacist
NPI: 1952697823Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03326691(OH)
Research & Publications (11)
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
PMID 19494788·J Thorac Oncol·2009
3-trial
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
PMID 19010874·Clin Cancer Res·2008
3-trial
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
PMID 18165643·J Clin Oncol·2008
3-trial
Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
PMID 16779984·J Reprod Med·2006
8-other
Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin.
PMID 16406065·Gynecol Oncol·2006
8-other
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
PMID 15721401·Gynecol Oncol·2005
3-trial
Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study.
PMID 15262126·Gynecol Oncol·2004
3-trial
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
PMID 15184995·Cancer Chemother Pharmacol·2004
3-trial
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.
PMID 14508840·Cancer·2003
4-observational
Predictive validity and reliability of adult hearing screening techniques.
PMID 12833924·J Am Acad Audiol·2003
4-observational
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
PMID 11251003·J Clin Oncol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 240 MARKET DR, T-1215
ELYRIA, OH 44035 - Phone
- (440) 324-2339
Quick Facts
- NPI
- 1952697823
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 11
Are you this provider?
Claim Your Profile